Something else that hasn't been mentioned is the significant cost of running trials. Halving the patients will be a massive expenditure not needeed. While highly unlikely to halve the cost, it could potentially save us a quarter or even a third of the original forecast expense as compared to what it would have cost a week ago. I think our q4 books are going to look pretty good.
- Forums
- ASX - By Stock
- IMU
- Imugene - Charts & Price Action (New thread)
Imugene - Charts & Price Action (New thread), page-831
-
- There are more pages in this discussion • 968 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $407.8M |
Open | High | Low | Value | Volume |
5.6¢ | 5.6¢ | 5.5¢ | $262.8K | 4.759M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 306861 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 987098 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 513619 | 0.055 |
26 | 2155366 | 0.054 |
11 | 751591 | 0.053 |
20 | 1669549 | 0.052 |
17 | 2460434 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 696098 | 19 |
0.057 | 462042 | 7 |
0.058 | 622333 | 5 |
0.059 | 1037714 | 5 |
0.060 | 1058850 | 12 |
Last trade - 13.19pm 17/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |